人类胺2,3-二氧化原酶的抑制基质结合部位
Changyuan Lu1, Yu Lin, Syun-Ru Yeh
1Department of Physiology and Biophysics, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York 10461, USA.
Journal of the American Chemical Society
|September 10, 2009
概括
人类氨酸2,3-二氧化酶 (hIDO) 有一个新发现的抑制基质站点. 这一发现有助于开发新的癌症免疫疗法,并重新评估抗瘤剂米托米C.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
- 癌症生物学 癌症生物学
背景情况:
- 人类氨酸2,3-二氧化酶 (hIDO) 是一个细胞内酶,对L-托代谢至关重要.
- hIDO具有免疫抑制作用,使其成为癌症治疗的重要药物标.
研究的目的:
- 在hIDO.中研究潜在的抑制基质位点 (S(i)) 的结合特性.
- 为开发更有效的hIDO抑制剂用于癌症治疗提供见解.
主要方法:
- 酶动力学的研究.
- 用各种分子进行结合测试,包括基质,效应剂和抑制剂.
主要成果:
- 证据支持在hIDO.中有一个抑制基质结合位点 (S(i)).
- 这个部位结合了各种分子,如L-三,1-甲基-L-三,3-醇乙醇和米托米C.
结论:
- 已确定的S(i) 位点为设计强效hIDO抑制剂提供了一个目标.
- 基于这些发现,需要对米托米辛C的作用机制进行重新评估.
更多相关视频
08:31Anaerobic Protein Purification and Kinetic Analysis via Oxygen Electrode for Studying DesB Dioxygenase Activity and Inhibition
Published on: October 3, 2018
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
相关概念视频
Induced-fit Model
Most chemical reactions in cells require enzymes—biological catalysts that speed up the reaction without being consumed or permanently changed. They reduce the activation energy needed to convert the reactants into products. Enzymes are proteins, that usually work by binding to a substrate—a reactant molecule that they act upon.
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
Feedback Inhibition
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
Enzyme Inhibition
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Enzymes
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex, leading to...
